Jiangxi Shimei Pharmaceutical Co., Ltd.

The primary study objective was to investigate the pharmacokinetic characteristics of the test and reference formulations in healthy Chinese adults after oral administration in the fasting and fed states, and to evaluate the bioequivalence of the two formulations after oral administration in the fasting and fed states. The secondary study objective was to evaluate the safety of the test and reference formulations in healthy Chinese adults.

Primary study objectives: To investigate the pharmacokinetic characteristics of the test and reference formulations in healthy Chinese adults after oral administration in the fasting and fed states, and to evaluate the bioequivalence of the two formulations after oral administration in the fasting and fed states. Secondary study objectives: To evaluate the safety of the test and reference formulations in healthy Chinese adults.

Primary study objectives: To investigate the pharmacokinetic characteristics of the test and reference formulations in healthy Chinese adults after oral administration in the fasting and fed states, and to evaluate the bioequivalence of the two formulations after oral administration in the fasting and fed states. Secondary study objectives: To evaluate the safety of the test and reference formulations in healthy Chinese adults.